Article Versions Notes

Miyadera K, Kakuto S, Sugai M, Tsugitomi R, Amino Y, Uchibori K, Yanagitani N, Sugiura H, Seike M, Nishio M, et al. Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors. Cancers. 2024; 16(21):3712. https://doi.org/10.3390/cancers16213712

Miyadera, Keiki, Sho Kakuto, Mayu Sugai, Ryosuke Tsugitomi, Yoshiaki Amino, Ken Uchibori, Noriko Yanagitani, Hisatoshi Sugiura, Masahiro Seike, Makoto Nishio, and et al. 2024. "Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors" Cancers 16, no. 21: 3712. https://doi.org/10.3390/cancers16213712

Miyadera, K., Kakuto, S., Sugai, M., Tsugitomi, R., Amino, Y., Uchibori, K., Yanagitani, N., Sugiura, H., Seike, M., Nishio, M., & Ariyasu, R. (2024). Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors. Cancers, 16(21), 3712. https://doi.org/10.3390/cancers16213712